OKE
59
3
EXC
53
2
UNP
52
2
LLY
60
-7
ADI
63
2
LEG
13
2
GOOG
91
2
CTAS
62
7
FLR
50
-9
MA
58
3
GME
89
15
ADM
34
-2
D
46
11
FRT
58
-5
MDT
60
4
PNC
52
3
NKE
42
2
EXR
55
5
COP
42
-3
FTI
86
2
OKE
59
3
EXC
53
2
UNP
52
2
LLY
60
-7
ADI
63
2
LEG
13
2
GOOG
91
2
CTAS
62
7
FLR
50
-9
MA
58
3
GME
89
15
ADM
34
-2
D
46
11
FRT
58
-5
MDT
60
4
PNC
52
3
NKE
42
2
EXR
55
5
COP
42
-3
FTI
86
2
Financhill
Back

AnaptysBio 10K Form

Buy
73

ANAB
AnaptysBio

Last Price:
25.71
Seasonality Move:
-8.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio Quarterly
2023-08-07 10Q ANAB/AnaptysBio Quarterly
2023-05-11 10Q ANAB/AnaptysBio Quarterly
2022-11-08 10Q ANAB/AnaptysBio Quarterly
2022-08-08 10Q ANAB/AnaptysBio Quarterly
2022-05-04 10Q ANAB/AnaptysBio Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $17.16M
Cash Flow: $-34.63M
Price / Cash Flow: 0
Annual Sales: $3.31
Price / Book: 8.07

Profitability

EPS (TTM): -6.08000
Net Income (TTM): $-163.62M
Gross Margin: $5.48M
Return on Equity: -100.98%
Return on Assets: -31.24%

AnaptysBio Earnings Forecast

Key AnaptysBio Financial Ratios

  • The Gross Profit Margin over the past 1 years for ANAB is 100.00%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 244.48% of Gross Profit Margin.
  • The Research & Development expenses have been 771.01% of Revenue.
  • The Interest Expense is -11.05% of Operating Income.
  • The Net Earning history of ANAB is -953.66% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

AnaptysBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.87
Quick Ratio: 10.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Buy
73
AnaptysBio (ANAB) is a Buy

Is AnaptysBio a Buy or a Sell?

  • AnaptysBio stock is rated a Buy
    The current AnaptysBio [ANAB] share price is $26.58. The Score for ANAB is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.